{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:16:06Z","timestamp":1785269766050,"version":"3.55.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012001","name":"Al Jalila Foundation","doi-asserted-by":"publisher","award":["AJF2020006"],"award-info":[{"award-number":["AJF2020006"]}],"id":[{"id":"10.13039\/100012001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ASPIRE Grant","award":["AARE20-344"],"award-info":[{"award-number":["AARE20-344"]}]},{"DOI":"10.13039\/100020310","name":"ATRC","doi-asserted-by":"crossref","award":["VRI-20-10"],"award-info":[{"award-number":["VRI-20-10"]}],"id":[{"id":"10.13039\/100020310","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15248-6","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:57:38Z","timestamp":1755809858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["miRNA biomarkers for prognosis and therapy monitoring in a multi-ethnic cohort with SARS-CoV-2 infection"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-3756","authenticated-orcid":false,"given":"Farah","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-6558","authenticated-orcid":false,"given":"Waqar","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-3908","authenticated-orcid":false,"given":"Bushra","family":"Gull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-9846","authenticated-orcid":false,"given":"Jasmin","family":"Baby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7553-9006","authenticated-orcid":false,"given":"Neena G.","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1338-2568","authenticated-orcid":false,"given":"Thanumol Abdul","family":"Khader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-7387","authenticated-orcid":false,"given":"Hala Abdul","family":"Baki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erum","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0301-8265","authenticated-orcid":false,"given":"Asif M.","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina L. G.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7129-1138","authenticated-orcid":false,"given":"Hamda H.","family":"Khansaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Habous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila M. J. A.","family":"AlDabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6269-9759","authenticated-orcid":false,"given":"Soumeya","family":"Jaballah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1726-1587","authenticated-orcid":false,"given":"Saif S.","family":"Alqassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alawi","family":"Alsheikh-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2572-1678","authenticated-orcid":false,"given":"Tahir A.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"SI-1","key":"15248_CR1","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.3906\/sag-2107-13","volume":"51","author":"I Celik","year":"2021","unstructured":"Celik, I. & Ozturk, R. From asymptomatic to critical illness: decoding various clinical stages of COVID-19. Turk. J. Med. Sci. 51 (SI-1), 3284\u20133300 (2021).","journal-title":"Turk. J. Med. Sci."},{"issue":"3","key":"15248_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu, B. et al. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19 (3), 141\u2013154 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"15248_CR3","doi-asserted-by":"crossref","unstructured":"Clerbaux, L. A. et al. Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework. J Clin Med, 11(15). (2022).","DOI":"10.3390\/jcm11154464"},{"key":"15248_CR4","doi-asserted-by":"crossref","unstructured":"Jiang, Y. et al. Inflammatory pathways in COVID-19: Mechanism and therapeutic interventions. MedComm 2022. 3(3): p. e154. (2020).","DOI":"10.1002\/mco2.154"},{"key":"15248_CR5","doi-asserted-by":"crossref","unstructured":"Rabaan, A. A. et al. Diverse immunological factors influencing pathogenesis in patients with COVID-19: A review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses. Pathogens 10(5), 565 (2021).","DOI":"10.3390\/pathogens10050565"},{"issue":"4","key":"15248_CR6","doi-asserted-by":"publisher","first-page":"e28751","DOI":"10.1002\/jmv.28751","volume":"95","author":"MS Qudus","year":"2023","unstructured":"Qudus, M. S. et al. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection. J. Med. Virol. 95 (4), e28751 (2023).","journal-title":"J. Med. Virol."},{"key":"15248_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","volume":"40","author":"S Hojyo","year":"2020","unstructured":"Hojyo, S. et al. How COVID-19 induces cytokine storm with high mortality. Inflamm. Regen. 40, 37 (2020).","journal-title":"Inflamm. Regen"},{"key":"15248_CR8","doi-asserted-by":"publisher","first-page":"112420","DOI":"10.1016\/j.biopha.2021.112420","volume":"145","author":"M Farahani","year":"2022","unstructured":"Farahani, M. et al. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed. Pharmacother. 145, 112420 (2022).","journal-title":"Biomed. Pharmacother"},{"issue":"39","key":"15248_CR9","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.3748\/wjg.v28.i39.5666","volume":"28","author":"HHL Wu","year":"2022","unstructured":"Wu, H. H. L. et al. COVID-19 and hepatorenal syndrome. World J. Gastroenterol. 28 (39), 5666\u20135678 (2022).","journal-title":"World J. Gastroenterol."},{"key":"15248_CR10","doi-asserted-by":"publisher","first-page":"e11711","DOI":"10.1590\/1414-431x2021e11711","volume":"55","author":"J Fabiao","year":"2022","unstructured":"Fabiao, J. et al. Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age. Braz J. Med. Biol. Res. 55, e11711 (2022).","journal-title":"Braz J. Med. Biol. Res."},{"issue":"5","key":"15248_CR11","first-page":"CD013600","volume":"5","author":"C Iannizzi","year":"2023","unstructured":"Iannizzi, C. et al. Convalescent plasma for people with COVID-19: a living systematic review. Cochrane Database Syst. Rev. 5 (5), CD013600 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"15248_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ije\/dyad012","volume":"52","author":"C Kartsonaki","year":"2023","unstructured":"Kartsonaki, C. et al. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. Int. J. Epidemiol. 52 (2), 355\u2013376 (2023).","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"15248_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s43162-021-00092-7","volume":"34","author":"W Ahmad","year":"2022","unstructured":"Ahmad, W. & Shabbiri, K. Two years of SARS-CoV-2 infection (2019\u20132021): structural biology, vaccination, and current global situation. Egypt. J. Intern. Med. 34 (1), 5 (2022).","journal-title":"Egypt. J. Intern. Med."},{"key":"15248_CR14","doi-asserted-by":"crossref","unstructured":"Herbert, J. A. & Panagiotou, S. In Immune Response To Viruses. Encyclopedia of Infection and Immunity. Vol. 1 (ed. Rezaei, N.) 429-444 (Elsevier, 2022).","DOI":"10.1016\/B978-0-12-818731-9.00235-4"},{"key":"15248_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fcimb.2019.00095","volume":"9","author":"MMB Moreno-Altamirano","year":"2019","unstructured":"Moreno-Altamirano, M. M. B., Kolstoe, S. E. & Sanchez-Garcia, F. J. Virus control of cell metabolism for replication and evasion of host immune responses. Front. Cell. Infect. Microbiol. 9, 95 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"15248_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12038-010-0072-9","volume":"35","author":"D Adhya","year":"2010","unstructured":"Adhya, D. & Basu, A. Epigenetic modulation of host: new insights into immune evasion by viruses. J. Biosci. 35 (4), 647\u2013663 (2010).","journal-title":"J. Biosci."},{"issue":"Suppl 2(Suppl 2","key":"15248_CR17","doi-asserted-by":"publisher","first-page":"14560","DOI":"10.1073\/pnas.0404758101","volume":"101","author":"MR Hilleman","year":"2004","unstructured":"Hilleman, M. R. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl. Acad. Sci. U S A. 101 (Suppl 2(Suppl 2), 14560\u201314566 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"15248_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10238-020-00648-x","volume":"20","author":"M Gavriatopoulou","year":"2020","unstructured":"Gavriatopoulou, M. et al. Organ-specific manifestations of COVID-19 infection. Clin. Exp. Med. 20 (4), 493\u2013506 (2020).","journal-title":"Clin. Exp. Med."},{"key":"15248_CR19","doi-asserted-by":"crossref","unstructured":"Ahmad, W. et al. Differentially-regulated MiRNAs in COVID-19: A systematic review. Rev. Med. Virol. 33(4), e2449 (2023).","DOI":"10.1002\/rmv.2449"},{"key":"15248_CR20","doi-asserted-by":"crossref","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 369(6508), eabc8511 (2020).","DOI":"10.1126\/science.369.6508.1203-l"},{"key":"15248_CR21","doi-asserted-by":"publisher","first-page":"857573","DOI":"10.3389\/fimmu.2022.857573","volume":"13","author":"D Battaglini","year":"2022","unstructured":"Battaglini, D. et al. Laboratory biomarkers for diagnosis and prognosis in COVID-19. Front. Immunol. 13, 857573 (2022).","journal-title":"Front. Immunol."},{"key":"15248_CR22","doi-asserted-by":"publisher","first-page":"607647","DOI":"10.3389\/fped.2020.607647","volume":"8","author":"M Samprathi","year":"2020","unstructured":"Samprathi, M. & Jayashree, M. Biomarkers in COVID-19: an Up-To-Date review. Front. Pediatr. 8, 607647 (2020).","journal-title":"Front. Pediatr."},{"key":"15248_CR23","doi-asserted-by":"crossref","unstructured":"Luo, S. et al. Exploring potential biomarkers and molecular mechanisms of ischemic cardiomyopathy and COVID-19 comorbidity based on bioinformatics and systems biology. Int. J. Mol. Sci. 24(7), 6511 (2023).","DOI":"10.3390\/ijms24076511"},{"key":"15248_CR24","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.3389\/fmicb.2018.03185","volume":"9","author":"B Su","year":"2018","unstructured":"Su, B. et al. Potential application of MicroRNA profiling to the diagnosis and prognosis of HIV-1 infection. Front. Microbiol. 9, 3185 (2018).","journal-title":"Front. Microbiol."},{"issue":"4","key":"15248_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/art.23386","volume":"58","author":"J Stanczyk","year":"2008","unstructured":"Stanczyk, J. et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58 (4), 1001\u20131009 (2008).","journal-title":"Arthritis Rheum."},{"issue":"6","key":"15248_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.molmed.2011.01.006","volume":"17","author":"CA Andorfer","year":"2011","unstructured":"Andorfer, C. A. et al. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol. Med. 17 (6), 313\u2013319 (2011).","journal-title":"Trends Mol. Med."},{"key":"15248_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-7046-9_4","volume":"1617","author":"W Huang","year":"2017","unstructured":"Huang, W. MicroRNAs: biomarkers, diagnostics, and therapeutics. Methods Mol. Biol. 1617, 57\u201367 (2017).","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"15248_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41544-018-0004-7","volume":"1","author":"SA Leon-Icaza","year":"2019","unstructured":"Leon-Icaza, S. A., Zeng, M. & Rosas-Taraco, A. G. MicroRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines. ExRNA 1 (1), 1 (2019).","journal-title":"ExRNA"},{"issue":"1","key":"15248_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.molmed.2016.11.003","volume":"23","author":"DW Trobaugh","year":"2017","unstructured":"Trobaugh, D. W. & Klimstra, W. B. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol. Med. 23 (1), 80\u201393 (2017).","journal-title":"Trends Mol. Med."},{"issue":"12","key":"15248_CR30","doi-asserted-by":"publisher","first-page":"e1010091","DOI":"10.1371\/journal.ppat.1010091","volume":"17","author":"T Takahashi","year":"2021","unstructured":"Takahashi, T., Heaton, S. M. & Parrish, N. F. Mammalian antiviral systems directed by small RNA. PLoS Pathog. 17 (12), e1010091 (2021).","journal-title":"PLoS Pathog"},{"issue":"7487","key":"15248_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature12869","volume":"506","author":"DW Trobaugh","year":"2014","unstructured":"Trobaugh, D. W. et al. RNA viruses can hijack vertebrate MicroRNAs to suppress innate immunity. Nature 506 (7487), 245\u2013248 (2014).","journal-title":"Nature"},{"key":"15248_CR32","doi-asserted-by":"crossref","unstructured":"Ostrycharz, E. & Hukowska-Szematowicz, B. Micro-Players of great Significance-Host MicroRNA signature in viral infections in humans and animals. Int. J. Mol. Sci. 23(18), 10536 (2022).","DOI":"10.3390\/ijms231810536"},{"key":"15248_CR33","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3389\/fimmu.2018.01541","volume":"9","author":"TH Nguyen","year":"2018","unstructured":"Nguyen, T. H. et al. Potential role of MicroRNAs in the regulation of antiviral responses to influenza infection. Front. Immunol. 9, 1541 (2018).","journal-title":"Front. Immunol."},{"issue":"1","key":"15248_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12929-019-0614-x","volume":"27","author":"RR Wong","year":"2020","unstructured":"Wong, R. R. et al. Role of MicroRNAs in antiviral responses to dengue infection. J. Biomed. Sci. 27 (1), 4 (2020).","journal-title":"J. Biomed. Sci."},{"key":"15248_CR35","doi-asserted-by":"crossref","unstructured":"Megahed, F. et al. MicroRNAs: small molecules with significant functions, particularly in the context of viral hepatitis B and C infection. Med. (Kaunas) 59(1), 173. (2023).","DOI":"10.3390\/medicina59010173"},{"issue":"3","key":"15248_CR36","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1073\/pnas.1112263109","volume":"109","author":"T Shimakami","year":"2012","unstructured":"Shimakami, T. et al. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc. Natl. Acad. Sci. U S A. 109 (3), 941\u2013946 (2012).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"15248_CR37","doi-asserted-by":"publisher","first-page":"862642","DOI":"10.3389\/fgene.2022.862642","volume":"13","author":"R Chinniah","year":"2022","unstructured":"Chinniah, R. et al. The effect of MiRNA gene regulation on HIV disease. Front. Genet. 13, 862642 (2022).","journal-title":"Front. Genet."},{"key":"15248_CR38","doi-asserted-by":"crossref","unstructured":"Balasubramaniam, M., Pandhare, J. & Dash, C. Are MicroRNAs important players in HIV-1 infection?? An update. Viruses 10(3), 110 (2018).","DOI":"10.3390\/v10030110"},{"issue":"6","key":"15248_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener, C., Keller, A. & Meese, E. Emerging concepts of MiRNA therapeutics: from cells to clinic. Trends Genet. 38 (6), 613\u2013626 (2022).","journal-title":"Trends Genet."},{"key":"15248_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-42059-2_1","volume":"937","author":"S Hombach","year":"2016","unstructured":"Hombach, S. & Kretz, M. Non-coding rnas: classification, biology and functioning. Adv. Exp. Med. Biol. 937, 3\u201317 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"15248_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00004424-197309000-00011","volume":"8","author":"JP Blakely","year":"1973","unstructured":"Blakely, J. P. Guest editorial: changes in radiology training. Invest. Radiol. 8 (5), 357\u2013359 (1973).","journal-title":"Invest. Radiol."},{"key":"15248_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fcell.2020.00409","volume":"8","author":"PJ Dexheimer","year":"2020","unstructured":"Dexheimer, P. J. & Cochella, L. MicroRNAs: from mechanism to organism. Front. Cell. Dev. Biol. 8, 409 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"15248_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.micro.112408.134243","volume":"64","author":"RL Skalsky","year":"2010","unstructured":"Skalsky, R. L. & Cullen, B. R. Viruses, micrornas, and host interactions. Annu. Rev. Microbiol. 64, 123\u2013141 (2010).","journal-title":"Annu. Rev. Microbiol."},{"key":"15248_CR44","doi-asserted-by":"crossref","unstructured":"Benesova, S., Kubista, M. & Valihrach, L. Small RNA-Sequencing: approaches and considerations for MiRNA analysis. Diagnostics (Basel) 11(6), 964 (2021).","DOI":"10.3390\/diagnostics11060964"},{"issue":"3","key":"15248_CR45","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s12010-021-03728-0","volume":"194","author":"D MubarakAli","year":"2022","unstructured":"MubarakAli, D. Comprehensive review on rapid diagnosis of new infection COVID-19. Appl. Biochem. Biotechnol. 194 (3), 1390\u20131400 (2022).","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"15248_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s42247-021-00169-7","volume":"4","author":"EA Tarim","year":"2021","unstructured":"Tarim, E. A. et al. Microfluidic-based virus detection methods for respiratory diseases. Emergent Mater. 4 (1), 143\u2013168 (2021).","journal-title":"Emergent Mater."},{"issue":"5","key":"15248_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard, C. C., Cheng, H. H. & Tewari, M. MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 13 (5), 358\u2013369 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"15248_CR48","doi-asserted-by":"crossref","unstructured":"Eichmeier, A. et al. Conserved MicroRNAs in human nasopharynx tissue samples from swabs are differentially expressed in response to SARS-CoV-2. Genes (Basel) 13(2), 348 (2022).","DOI":"10.3390\/genes13020348"},{"issue":"4","key":"15248_CR49","doi-asserted-by":"publisher","first-page":"e0265670","DOI":"10.1371\/journal.pone.0265670","volume":"17","author":"RJ Farr","year":"2022","unstructured":"Farr, R. J. et al. Detection of SARS-CoV-2 infection by MicroRNA profiling of the upper respiratory tract. PLoS One. 17 (4), e0265670 (2022).","journal-title":"PLoS One"},{"issue":"19","key":"15248_CR50","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1111\/jcmm.17492","volume":"26","author":"A Latini","year":"2022","unstructured":"Latini, A. et al. Expression analysis of MiRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors. J. Cell. Mol. Med. 26 (19), 4940\u20134948 (2022).","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"15248_CR51","doi-asserted-by":"publisher","first-page":"109839","DOI":"10.1016\/j.celrep.2021.109839","volume":"37","author":"JT McDonald","year":"2021","unstructured":"McDonald, J. T. et al. Role of miR-2392 in driving SARS-CoV-2 infection. Cell. Rep. 37 (3), 109839 (2021).","journal-title":"Cell. Rep."},{"issue":"1","key":"15248_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix120","volume":"7","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. SOAPnuke: a mapreduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data. Gigascience 7 (1), 1\u20136 (2018).","journal-title":"Gigascience"},{"key":"15248_CR53","doi-asserted-by":"crossref","unstructured":"Wingett, S. W. & Andrews, S. FastQ Screen: A tool for multi-genome mapping and quality control. F1000Res, 7: p. 1338. (2018).","DOI":"10.12688\/f1000research.15931.2"},{"issue":"4","key":"15248_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with bowtie 2. Nat. Methods. 9 (4), 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"issue":"12","key":"15248_CR55","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15 (12), 550 (2014).","journal-title":"Genome Biol."},{"issue":"2","key":"15248_CR56","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2144\/03342mt01","volume":"34","author":"AI Saeed","year":"2003","unstructured":"Saeed, A. I. et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2), 374\u2013378 (2003).","journal-title":"Biotechniques"},{"issue":"D1","key":"15248_CR57","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Wang, X. MiRDB: an online database for prediction of functional MicroRNA targets. Nucleic Acids Res. 48 (D1), D127\u2013D131 (2020).","journal-title":"Nucleic Acids Res."},{"key":"15248_CR58","doi-asserted-by":"crossref","unstructured":"McGeary, S. E. et al. The biochemical basis of MicroRNA targeting efficacy. Science 366(6472), eaav1741 (2019).","DOI":"10.1126\/science.aav1741"},{"key":"15248_CR59","doi-asserted-by":"crossref","unstructured":"Tastsoglou, S. et al. DIANA-microT 2023: Including Predicted Targets of Virally Encoded miRNAs (Nucleic Acids Res, 2023).","DOI":"10.1093\/nar\/gkad283"},{"issue":"D1","key":"15248_CR60","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2022","unstructured":"Huang, H. Y. et al. MiRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 50 (D1), D222\u2013D230 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"15248_CR61","doi-asserted-by":"publisher","first-page":"D142","DOI":"10.1093\/nar\/gkz1022","volume":"48","author":"T Kehl","year":"2020","unstructured":"Kehl, T. et al. MiRPathDB 2.0: a novel release of the MiRNA pathway dictionary database. Nucleic Acids Res. 48 (D1), D142\u2013D147 (2020).","journal-title":"Nucleic Acids Res."},{"key":"15248_CR62","doi-asserted-by":"crossref","unstructured":"Das, S. S., Saha, P. & Chakravorty, N. miRwayDB: a database for experimentally validated microRNA-pathway associations in pathophysiological conditions. Database (Oxford), 2018. (2018).","DOI":"10.1093\/database\/bay023"},{"issue":"1","key":"15248_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4 (1), 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"issue":"D1","key":"15248_CR64","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M. et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"15248_CR65","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1074\/mcp.TIR120.002155","volume":"19","author":"J Griss","year":"2020","unstructured":"Griss, J. et al. ReactomeGSA - Efficient Multi-Omics comparative pathway analysis. Mol. Cell. Proteom. 19 (12), 2115\u20132125 (2020).","journal-title":"Mol. Cell. Proteom."},{"key":"15248_CR66","doi-asserted-by":"publisher","first-page":"100043","DOI":"10.1016\/j.bioflm.2021.100043","volume":"3","author":"T Coenye","year":"2021","unstructured":"Coenye, T. Do results obtained with RNA-sequencing require independent verification? Biofilm 3, 100043 (2021).","journal-title":"Biofilm"},{"issue":"1","key":"15248_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm, F. S. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J. Anesthesiol. 75 (1), 25\u201336 (2022).","journal-title":"Korean J. Anesthesiol"},{"key":"15248_CR68","doi-asserted-by":"publisher","first-page":"3762651","DOI":"10.1155\/2017\/3762651","volume":"2017","author":"I Unal","year":"2017","unstructured":"Unal, I. Defining an optimal Cut-Point value in ROC analysis: an alternative approach. Comput. Math. Methods Med. 2017, 3762651 (2017).","journal-title":"Comput. Math. Methods Med."},{"issue":"Suppl 1(Suppl 1","key":"15248_CR69","first-page":"S83","volume":"29","author":"CM Florkowski","year":"2008","unstructured":"Florkowski, C. M. Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. Clin. Biochem. Rev. 29 (Suppl 1(Suppl 1), S83\u2013S87 (2008).","journal-title":"Clin. Biochem. Rev."},{"issue":"6","key":"15248_CR70","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2217\/bmm-2021-0681","volume":"16","author":"S Araya","year":"2022","unstructured":"Araya, S. et al. Organ function biomarker abnormalities, associated factors and disease outcome among hospitalized patients with COVID-19. Biomark. Med. 16 (6), 417\u2013426 (2022).","journal-title":"Biomark. Med."},{"issue":"4","key":"15248_CR71","doi-asserted-by":"publisher","first-page":"e2449","DOI":"10.1002\/rmv.2449","volume":"33","author":"W Ahmad","year":"2023","unstructured":"Ahmad, W. et al. Differentially-regulated MiRNAs in COVID-19: A systematic review. Rev. Med. Virol. 33 (4), e2449 (2023).","journal-title":"Rev. Med. Virol."},{"issue":"24","key":"15248_CR72","doi-asserted-by":"publisher","first-page":"e105896","DOI":"10.15252\/embj.2020105896","volume":"39","author":"YM Chen","year":"2020","unstructured":"Chen, Y. M. et al. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. EMBO J. 39 (24), e105896 (2020).","journal-title":"EMBO J."},{"issue":"7","key":"15248_CR73","doi-asserted-by":"publisher","first-page":"e1009759","DOI":"10.1371\/journal.ppat.1009759","volume":"17","author":"RJ Farr","year":"2021","unstructured":"Farr, R. J. et al. Altered MicroRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 17 (7), e1009759 (2021).","journal-title":"PLoS Pathog"},{"issue":"1","key":"15248_CR74","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/22221751.2022.2038021","volume":"11","author":"A Fernandez-Pato","year":"2022","unstructured":"Fernandez-Pato, A. et al. Plasma MiRNA profile at COVID-19 onset predicts severity status and mortality. Emerg. Microbes Infect. 11 (1), 676\u2013688 (2022).","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"15248_CR75","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1038\/s41598-022-10738-3","volume":"12","author":"N Garcia-Giralt","year":"2022","unstructured":"Garcia-Giralt, N. et al. Circulating MicroRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection. Sci. Rep. 12 (1), 6929 (2022).","journal-title":"Sci. Rep."},{"key":"15248_CR76","doi-asserted-by":"crossref","unstructured":"Grehl, C. et al. Detection of SARS-CoV-2 derived small RNAs and changes in Circulating small RNAs associated with COVID-19. Viruses 13(8), 1593 (2021).","DOI":"10.3390\/v13081593"},{"issue":"10","key":"15248_CR77","doi-asserted-by":"publisher","first-page":"e23590","DOI":"10.1002\/jcla.23590","volume":"34","author":"C Li","year":"2020","unstructured":"Li, C. et al. Differential MicroRNA expression in the peripheral blood from human patients with COVID-19. J. Clin. Lab. Anal. 34 (10), e23590 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"15248_CR78","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.2147\/IDR.S372420","volume":"15","author":"X Li","year":"2022","unstructured":"Li, X. et al. Potential predictive value of miR-125b-5p, miR-155-5p and their target genes in the course of COVID-19. Infect. Drug Resist. 15, 4079\u20134091 (2022).","journal-title":"Infect. Drug Resist."},{"issue":"7","key":"15248_CR79","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1007\/s11033-022-07338-9","volume":"49","author":"AS Nicoletti","year":"2022","unstructured":"Nicoletti, A. S. et al. Differentially expressed plasmatic MicroRNAs in Brazilian patients with coronavirus disease 2019 (COVID-19): preliminary results. Mol. Biol. Rep. 49 (7), 6931\u20136943 (2022).","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"15248_CR80","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41392-020-00457-4","volume":"5","author":"HY Zheng","year":"2020","unstructured":"Zheng, H. Y. et al. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19. Signal. Transduct. Target. Ther. 5 (1), 294 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"15248_CR81","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/cvr\/cvab338","volume":"118","author":"C Gutmann","year":"2022","unstructured":"Gutmann, C. et al. Association of cardiometabolic MicroRNAs with COVID-19 severity and mortality. Cardiovasc. Res. 118 (2), 461\u2013474 (2022).","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"15248_CR82","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1002\/ctm2.200","volume":"10","author":"H Tang","year":"2020","unstructured":"Tang, H. et al. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19. Clin. Transl Med. 10 (6), e200 (2020).","journal-title":"Clin. Transl Med."},{"issue":"1","key":"15248_CR83","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41392-022-00969-1","volume":"7","author":"Q Zhao","year":"2022","unstructured":"Zhao, Q. et al. Identification of a SARS-CoV-2 virus-encoded small non-coding RNA in association with the neurological disorders in COVID-19 patients. Signal. Transduct. Target. Ther. 7 (1), 107 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"15248_CR84","doi-asserted-by":"crossref","unstructured":"Soltane, R. et al. A comparative analysis of MicroRNA expression in mild, moderate, and severe COVID-19: insights from urine, serum, and nasopharyngeal samples. Biomolecules 13(12), 1681 (2023).","DOI":"10.3390\/biom13121681"},{"issue":"6","key":"15248_CR85","doi-asserted-by":"publisher","first-page":"e899","DOI":"10.1002\/ctm2.899","volume":"12","author":"N Garnier","year":"2022","unstructured":"Garnier, N. et al. Altered MicroRNA expression in severe COVID-19: potential prognostic and pathophysiological role. Clin. Transl Med. 12 (6), e899 (2022).","journal-title":"Clin. Transl Med."},{"key":"15248_CR86","doi-asserted-by":"publisher","first-page":"821137","DOI":"10.3389\/fmolb.2022.821137","volume":"9","author":"W Wu","year":"2022","unstructured":"Wu, W. et al. Changes of small Non-coding RNAs by severe acute respiratory syndrome coronavirus 2 infection. Front. Mol. Biosci. 9, 821137 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"15248_CR87","doi-asserted-by":"publisher","first-page":"756517","DOI":"10.3389\/fmed.2021.756517","volume":"8","author":"M Molinero","year":"2021","unstructured":"Molinero, M. et al. Bronchial Aspirate-Based profiling identifies MicroRNA signatures associated with COVID-19 and fatal disease in critically ill patients. Front. Med. (Lausanne). 8, 756517 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"15248_CR88","doi-asserted-by":"crossref","unstructured":"Jankovic, M. et al. MiRNAs as a potential biomarker in the COVID-19 infection and complications course, severity, and outcome. Diagnostics (Basel), 13(6), 1091 (2023).","DOI":"10.3390\/diagnostics13061091"},{"issue":"13","key":"15248_CR89","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1093\/nar\/gkq167","volume":"38","author":"C Backes","year":"2010","unstructured":"Backes, C. et al. A dictionary on MicroRNAs and their putative target pathways. Nucleic Acids Res. 38 (13), 4476\u20134486 (2010).","journal-title":"Nucleic Acids Res."},{"issue":"Suppl 3","key":"15248_CR90","doi-asserted-by":"publisher","first-page":"iii50","DOI":"10.1136\/ard.2008.100289","volume":"67","author":"FJ Sheedy","year":"2008","unstructured":"Sheedy, F. J. & O\u2019Neill, L. A. Adding fuel to fire: MicroRNAs as a new class of mediators of inflammation. Ann. Rheum. Dis. 67 (Suppl 3), iii50\u2013iii55 (2008).","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"15248_CR91","doi-asserted-by":"publisher","first-page":"e0179850","DOI":"10.1371\/journal.pone.0179850","volume":"12","author":"D Pfeiffer","year":"2017","unstructured":"Pfeiffer, D. et al. miR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an in vitro sepsis model. PLoS One. 12 (6), e0179850 (2017).","journal-title":"PLoS One"},{"key":"15248_CR92","doi-asserted-by":"publisher","first-page":"663726","DOI":"10.3389\/fimmu.2021.663726","volume":"12","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. MiR-154-5p-MCP1 axis regulates allergic inflammation by mediating cellular interactions. Front. Immunol. 12, 663726 (2021).","journal-title":"Front. Immunol."},{"issue":"4","key":"15248_CR93","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.rbmo.2018.05.007","volume":"37","author":"P Pateisky","year":"2018","unstructured":"Pateisky, P. et al. hsa-miRNA-154-5p expression in plasma of endometriosis patients is a potential diagnostic marker for the disease. Reprod. Biomed. Online. 37 (4), 449\u2013466 (2018).","journal-title":"Reprod. Biomed. Online"},{"issue":"6","key":"15248_CR94","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.immuni.2009.09.019","volume":"31","author":"I Shaked","year":"2009","unstructured":"Shaked, I. et al. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31 (6), 965\u2013973 (2009).","journal-title":"Immunity"},{"key":"15248_CR95","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s12935-020-01595-z","volume":"20","author":"X Du","year":"2020","unstructured":"Du, X. et al. MiR-1307-5p targeting TRAF3 upregulates the MAPK\/NF-kappaB pathway and promotes lung adenocarcinoma proliferation. Cancer Cell. Int. 20, 502 (2020).","journal-title":"Cancer Cell. Int."},{"key":"15248_CR96","doi-asserted-by":"publisher","first-page":"747616","DOI":"10.3389\/fimmu.2021.747616","volume":"12","author":"L Wu","year":"2021","unstructured":"Wu, L. et al. Downregulation of renal Hsa-miR-127-3p contributes to the overactivation of type I interferon signaling pathway in the kidney of lupus nephritis. Front. Immunol. 12, 747616 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"15248_CR97","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1080\/21655979.2021.1979439","volume":"12","author":"S Hu","year":"2021","unstructured":"Hu, S. et al. Identification of MicroRNA hsa-miR-30c-5p as an inhibitory factor in the progression of hepatocellular carcinoma and investigation of its regulatory network via comprehensive analysis. Bioengineered 12 (1), 7165\u20137177 (2021).","journal-title":"Bioengineered"},{"issue":"1","key":"15248_CR98","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/carcin\/bgr245","volume":"33","author":"J Nie","year":"2012","unstructured":"Nie, J. et al. microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. Carcinogenesis 33 (1), 220\u2013225 (2012).","journal-title":"Carcinogenesis"},{"key":"15248_CR99","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.2147\/OTT.S305098","volume":"14","author":"L Ye","year":"2021","unstructured":"Ye, L. et al. Functions and targets of miR-335 in cancer. Onco Targets Ther. 14, 3335\u20133349 (2021).","journal-title":"Onco Targets Ther."},{"issue":"4","key":"15248_CR100","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1038\/oncsis.2014.12","volume":"3","author":"TI Hsu","year":"2014","unstructured":"Hsu, T. I. et al. MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo. Oncogenesis 3 (4), e99 (2014).","journal-title":"Oncogenesis"},{"key":"15248_CR101","doi-asserted-by":"crossref","unstructured":"Soronen, J. et al. Novel hepatic MicroRNAs upregulated in human nonalcoholic fatty liver disease. Physiol. Rep. 4(1), e12661 (2016).","DOI":"10.14814\/phy2.12661"},{"key":"15248_CR102","doi-asserted-by":"crossref","unstructured":"Ahmed, E. A., Rajendran, P. & Scherthan, H. The microRNA-202 as a diagnostic biomarker and a potential tumor suppressor. Int. J. Mol. Sci. 23(11), 5870 (2022).","DOI":"10.3390\/ijms23115870"},{"key":"15248_CR103","doi-asserted-by":"crossref","unstructured":"Costanzo, M., De Giglio, M. A. R. & Roviello, G. N. Deciphering the relationship between SARS-CoV-2 and cancer. Int. J. Mol. Sci. 24(9), 7803 (2023).","DOI":"10.3390\/ijms24097803"},{"issue":"4","key":"15248_CR104","doi-asserted-by":"publisher","first-page":"e0001523","DOI":"10.1128\/cmr.00015-23","volume":"36","author":"M Kimura","year":"2023","unstructured":"Kimura, M. et al. MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets. Clin. Microbiol. Rev. 36 (4), e0001523 (2023).","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"15248_CR105","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41392-023-01669-0","volume":"8","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets. Signal. Transduct. Target. Ther. 8 (1), 441 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"15248_CR106","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-0716-4290-0_3","volume":"2883","author":"H Janga","year":"2025","unstructured":"Janga, H. et al. Non-coding RNA networks in infection. Methods Mol. Biol. 2883, 53\u201377 (2025).","journal-title":"Methods Mol. Biol."},{"key":"15248_CR107","doi-asserted-by":"publisher","first-page":"703936","DOI":"10.3389\/fimmu.2021.703936","volume":"12","author":"O Tamgue","year":"2021","unstructured":"Tamgue, O. et al. Non-Coding RNAs in the etiology and control of major and neglected human tropical diseases. Front. Immunol. 12, 703936 (2021).","journal-title":"Front. Immunol."},{"key":"15248_CR108","doi-asserted-by":"publisher","first-page":"116218","DOI":"10.1016\/j.bcp.2024.116218","volume":"224","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Comprehensive review for non-coding rnas: from mechanisms to therapeutic applications. Biochem. Pharmacol. 224, 116218 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"15248_CR109","doi-asserted-by":"publisher","first-page":"114469","DOI":"10.1016\/j.bcp.2021.114469","volume":"189","author":"B Baptista","year":"2021","unstructured":"Baptista, B. et al. Non-coding rnas: emerging from the discovery to therapeutic applications. Biochem. Pharmacol. 189, 114469 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"15248_CR110","doi-asserted-by":"crossref","unstructured":"Garbo, S. et al. Next RNA therapeutics: the mine of Non-Coding. Int. J. Mol. Sci. 23(13), 7471 (2022).","DOI":"10.3390\/ijms23137471"},{"issue":"5","key":"15248_CR111","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ncb2054","volume":"12","author":"D Lagos","year":"2010","unstructured":"Lagos, D. et al. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell. Biol. 12 (5), 513\u2013519 (2010).","journal-title":"Nat. Cell. Biol."},{"key":"15248_CR112","doi-asserted-by":"crossref","unstructured":"Zhang, F. et al. MicroRNA-132-3p suppresses type I IFN response through targeting IRF1 to facilitate H1N1 influenza A virus infection. Biosci. Rep. 39(12), BSR20192769 (2019).","DOI":"10.1042\/BSR20192769"},{"issue":"4","key":"15248_CR113","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10863-020-09839-3","volume":"52","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Up-regulation of miR-146b-3p protects septic mice with acute respiratory distress syndrome by inhibiting PI3K\/AKT signaling pathway. J. Bioenerg Biomembr. 52 (4), 229\u2013236 (2020).","journal-title":"J. Bioenerg Biomembr."},{"issue":"3","key":"15248_CR114","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ncrna.2020.08.002","volume":"5","author":"H Haddad","year":"2020","unstructured":"Haddad, H. & Walid, A. Z. MiRNA target prediction might explain the reduced transmission of SARS-CoV-2 in jordan, middle East. Noncoding RNA Res. 5 (3), 135\u2013143 (2020).","journal-title":"Noncoding RNA Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15248-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15248-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15248-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:00:14Z","timestamp":1757415614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15248-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15248"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15248-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the UAE University (UAEU) Human Research Ethics Committee (HREC approval no: ERH-2020-7219 2020-22) and the Dubai Scientific Research Ethics Committee (DSREC) of the Dubai Health Authority (DHA) (DSREC approval nos: DSREC-11\/2020_16 and DSREC-11\/2021_08). Consent was taken from each subject following DHA and UAEU established procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"30815"}}